Drug Shortage Report for KETOROLAC TROMETHAMINE INJECTION, USP
Report ID | 56521 |
Drug Identification Number | 02443376 |
Brand name | KETOROLAC TROMETHAMINE INJECTION, USP |
Common or Proper name | Ketorolac |
Company Name | JUNO PHARMACEUTICALS CORP. |
Market Status | MARKETED |
Active Ingredient(s) | KETOROLAC TROMETHAMINE |
Strength(s) | 30MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1 ml Vial |
ATC code | M01AB |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-07-20 |
Actual start date | 2018-07-25 |
Estimated end date | 2018-10-29 |
Actual end date | 2018-10-31 |
Shortage status | Resolved |
Updated date | 2018-11-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2233 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 2X7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-11-05 | French | Compare |
v6 | 2018-11-05 | English | Compare |
v5 | 2018-10-23 | French | Compare |
v4 | 2018-10-23 | English | Compare |
v3 | 2018-07-26 | English | Compare |
v2 | 2018-07-25 | French | Compare |
v1 | 2018-07-25 | English | Compare |
Showing 1 to 7 of 7